DEXCOM, INC. Cost of Revenue
DEXCOM, INC. (DXCM) reported Cost of Revenue of $194.90 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2017-02-28
- DEXCOM, INC. cost of revenue for the quarter ending 2015-12-31 was $39.60M, a 59.04% increase year-over-year.
- DEXCOM, INC. cost of revenue for the quarter ending 2015-09-30 was $30.50M, a 39.91% increase year-over-year.
- DEXCOM, INC. cost of revenue for the quarter ending 2015-06-30 was $27.20M, a 43.92% increase year-over-year.
- DEXCOM, INC. cost of revenue for the quarter ending 2015-03-31 was $26.30M, a 52.02% increase year-over-year.
- DEXCOM, INC. cost of revenue for fiscal 2016 was $194.90M, a 57.69% increase from fiscal 2015.
- DEXCOM, INC. cost of revenue for fiscal 2015 was $123.60M, a 49.10% increase from fiscal 2014.
- DEXCOM, INC. cost of revenue for fiscal 2014 was $82.90M, a 38.40% increase from fiscal 2013.
- DEXCOM, INC. cost of revenue for fiscal 2013 was $59.90M, a 12.38% increase from fiscal 2012.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $194.90M 10-K · filed 2017-02-28 | |||||||
| 2015-12-31 | $39.60M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $70.10M derived: sum of 2 quarters · filed 2017-02-28 | $97.30M derived: sum of 3 quarters · filed 2017-02-28 | $123.60M 10-K · filed 2017-02-28 | ||||
| 2015-09-30 | $30.50M 10-Q · filed 2015-11-04 | $57.70M derived: sum of 2 quarters · filed 2015-11-04 | $84.00M 10-Q · filed 2015-11-04 | $108.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-06-30 | $27.20M 10-Q · filed 2015-08-05 | $53.50M 10-Q · filed 2015-08-05 | $78.40M derived: sum of 3 quarters · filed 2017-02-28 | $100.20M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $26.30M 10-Q · filed 2015-04-29 | $51.20M derived: sum of 2 quarters · filed 2017-02-28 | $73.00M derived: sum of 3 quarters · filed 2017-02-28 | $91.90M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $24.90M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $46.70M derived: sum of 2 quarters · filed 2017-02-28 | $65.60M derived: sum of 3 quarters · filed 2017-02-28 | $82.90M 10-K · filed 2017-02-28 | ||||
| 2014-09-30 | $21.80M 10-Q · filed 2015-11-04 | $40.70M derived: sum of 2 quarters · filed 2015-11-04 | $58.00M 10-Q · filed 2015-11-04 | $75.60M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-06-30 | $18.90M 10-Q · filed 2015-08-05 | $36.20M 10-Q · filed 2015-08-05 | $53.80M derived: sum of 3 quarters · filed 2016-02-23 | $69.10M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2014-03-31 | $17.30M 10-Q · filed 2015-04-29 | $34.90M derived: sum of 2 quarters · filed 2016-02-23 | $50.20M derived: sum of 3 quarters · filed 2016-02-23 | $64.10M derived: sum of 4 quarters · filed 2016-02-23 | ||||
| 2013-12-31 | $17.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $32.90M derived: sum of 2 quarters · filed 2016-02-23 | $46.80M derived: sum of 3 quarters · filed 2016-02-23 | $59.90M 10-K · filed 2016-02-23 | ||||
| 2013-09-30 | $15.30M 10-Q · filed 2014-11-06 | $29.20M derived: sum of 2 quarters · filed 2014-11-06 | $42.30M 10-Q · filed 2014-11-06 | $58.00M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $13.90M 10-Q · filed 2014-08-06 | $27.00M 10-Q · filed 2014-08-06 | $42.70M derived: sum of 3 quarters · filed 2015-02-25 | $57.40M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $13.10M 10-Q · filed 2014-05-01 | $28.80M derived: sum of 2 quarters · filed 2015-02-25 | $43.50M derived: sum of 3 quarters · filed 2015-02-25 | $55.70M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $15.70M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $30.40M derived: sum of 2 quarters · filed 2015-02-25 | $42.60M derived: sum of 3 quarters · filed 2015-02-25 | $53.30M 10-K · filed 2015-02-25 | ||||
| 2012-09-30 | $14.70M 10-Q · filed 2013-11-06 | $14.69M 10-Q · filed 2012-11-01 | $26.90M derived: sum of 2 quarters · filed 2013-11-06 | $37.60M 10-Q · filed 2013-11-06 | $37.60M 10-Q · filed 2012-11-01 | $49.31M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-06-30 | $12.20M 10-Q · filed 2013-08-07 | $12.21M 10-Q · filed 2012-08-06 | $22.90M 10-Q · filed 2013-08-07 | $22.91M 10-Q · filed 2012-08-06 | $34.61M derived: sum of 3 quarters · filed 2014-02-20 | $44.70M derived: sum of 4 quarters · filed 2014-02-20 | ||
| 2012-03-31 | $10.70M 10-Q · filed 2013-05-01 | $10.71M 10-Q · filed 2012-05-02 | $22.41M derived: sum of 2 quarters · filed 2014-02-20 | $32.50M derived: sum of 3 quarters · filed 2014-02-20 | $42.04M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | $11.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $21.80M derived: sum of 2 quarters · filed 2014-02-20 | $31.34M derived: sum of 3 quarters · filed 2014-02-20 | $40.40M 10-K · filed 2014-02-20 | $40.42M 10-K · filed 2012-02-23 | |||
| 2011-09-30 | $10.09M 10-Q · filed 2012-11-01 | $19.64M derived: sum of 2 quarters · filed 2012-11-01 | $28.69M 10-Q · filed 2012-11-01 | $37.35M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-06-30 | $9.55M 10-Q · filed 2012-08-06 | $18.60M 10-Q · filed 2012-08-06 | $27.26M derived: sum of 3 quarters · filed 2013-02-21 | $35.45M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2011-03-31 | $9.06M 10-Q · filed 2012-05-02 | $17.72M derived: sum of 2 quarters · filed 2013-02-21 | $25.91M derived: sum of 3 quarters · filed 2013-02-21 | $33.17M derived: sum of 4 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | $16.85M derived: sum of 2 quarters · filed 2013-02-21 | $24.11M derived: sum of 3 quarters · filed 2013-02-21 | $30.20M 10-K · filed 2013-02-21 | $30.19M 10-K · filed 2012-02-23 | |||
| 2010-09-30 | $8.19M 10-Q · filed 2011-11-02 | $15.46M derived: sum of 2 quarters · filed 2011-11-02 | $21.54M 10-Q · filed 2011-11-02 | |||||
| 2010-06-30 | $7.27M 10-Q · filed 2011-08-03 | $13.35M 10-Q · filed 2011-08-03 | ||||||
| 2009-12-31 | $26.03M 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |